Total Payments
$5,652
2024 Payments
$351.47
Companies
50
Transactions
356
Medicare Patients
1,942
Medicare Billing
$261,843
Payment Breakdown by Category
Food & Beverage$5,642 (99.8%)
Education$10.17 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,642 | 353 | 99.8% |
| Education | $10.17 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $520.14 | 34 | $0 (2024) |
| Amgen Inc. | $503.97 | 31 | $0 (2022) |
| Merck Sharp & Dohme LLC | $493.41 | 29 | $0 (2024) |
| Allergan, Inc. | $411.29 | 19 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $392.41 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $351.46 | 34 | $0 (2021) |
| Lilly USA, LLC | $293.56 | 13 | $0 (2024) |
| ABBVIE INC. | $251.16 | 23 | $0 (2023) |
| Novo Nordisk Inc | $222.72 | 17 | $0 (2024) |
| Medicure Pharma Inc. | $216.87 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.47 | 14 | Lilly USA, LLC ($121.95) |
| 2023 | $216.51 | 12 | PFIZER INC. ($38.98) |
| 2022 | $561.05 | 39 | ABBVIE INC. ($123.26) |
| 2021 | $400.62 | 25 | Biohaven Pharmaceuticals, Inc. ($59.22) |
| 2020 | $694.52 | 37 | Medicure Pharma Inc. ($178.96) |
| 2019 | $937.96 | 51 | Allergan Inc. ($244.75) |
| 2018 | $989.58 | 74 | Amgen Inc. ($162.95) |
| 2017 | $1,500 | 104 | Merck Sharp & Dohme Corporation ($310.49) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $121.95 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: VACCINES | ||||||
| 07/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Medical Device | ||||||
| 06/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: PAIN | ||||||
| 05/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes Care | ||||||
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Oncology | ||||||
| 04/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Obesity | ||||||
| 03/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiology | ||||||
| 02/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: VACCINE | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: UROLOGY | ||||||
| 11/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Gastroenterology | ||||||
| 11/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $32.71 | General |
| Category: Cardiovascular Device | ||||||
| 06/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Gastroenterology | ||||||
| 05/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: DERMATOLOGY | ||||||
| 04/17/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiology | ||||||
| 03/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: UROLOGY | ||||||
| 01/19/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 178 | 260 | $37,249 | $19,226 |
| 2022 | 13 | 408 | 667 | $91,765 | $49,494 |
| 2021 | 15 | 713 | 1,430 | $193,087 | $104,926 |
| 2020 | 16 | 643 | 1,222 | $166,607 | $88,197 |
Total Patients
1,942
Total Services
3,579
Medicare Billing
$261,843
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 78 | $14,274 | $6,481 | 45.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 42 | $10,710 | $5,001 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 48 | $6,192 | $2,819 | 45.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $2,850 | $2,423 | 85.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $1,770 | $1,582 | 89.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $880.00 | $663.30 | 75.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $420.00 | $219.36 | 52.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 17 | $153.00 | $37.40 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 217 | $39,711 | $20,774 | 52.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 80 | $20,400 | $10,647 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 107 | $13,803 | $6,985 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $4,050 | $3,568 | 88.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $4,440 | $2,704 | 60.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $2,550 | $2,330 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,360 | $997.56 | 73.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 65 | $2,340 | $644.87 | 27.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 29 | $1,566 | $312.56 | 20.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 13 | 13 | $585.00 | $231.05 | 39.5% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 13 | 13 | $585.00 | $205.20 | 35.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 14 | 17 | $204.00 | $53.11 | 26.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 19 | $171.00 | $42.33 | 24.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 165 | 500 | $76,000 | $41,283 | 54.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 109 | 283 | $30,564 | $16,264 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 152 | $26,334 | $14,366 | 54.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 144 | 166 | $28,054 | $13,924 | 49.6% |
About Dr. Stephen Reinhardt, MD
Dr. Stephen Reinhardt, MD is a Family Medicine healthcare provider based in North Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437101250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Reinhardt, MD has received a total of $5,652 in payments from pharmaceutical and medical device companies, with $351.47 received in 2024. These payments were reported across 356 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,642).
As a Medicare-enrolled provider, Reinhardt has provided services to 1,942 Medicare beneficiaries, totaling 3,579 services with total Medicare billing of $261,843. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location North Chesterfield, VA
- Active Since 05/17/2006
- Last Updated 07/24/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437101250
Products in Payments
- FARXIGA (Drug) $292.40
- DALVANCE (Drug) $247.23
- Aimovig (Biological) $238.74
- XARELTO (Drug) $230.80
- BELSOMRA (Drug) $207.28
- HMG-CoA reductase inhibitor. (Drug) $178.96
- ELIQUIS (Drug) $170.35
- CHANTIX (Drug) $161.36
- JANUVIA (Drug) $156.43
- NURTEC ODT (Drug) $138.05
- TOUJEO (Drug) $129.46
- KISUNLA (Drug) $121.95
- INVOKANA (Drug) $120.66
- Prolia (Biological) $119.58
- NUEDEXTA (Drug) $105.85
- TRULICITY (Drug) $102.44
- LINZESS (Drug) $98.29
- VIAGRA (Drug) $94.97
- XIFAXAN (Drug) $91.64
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $90.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in North Chesterfield
Mr. Jerome Daniel, Md, MD
Family Medicine — Payments: $23,023
Family Medicine $23,023
Sara Breeden, Md, MD
Family Medicine — Payments: $7,527
Family Medicine $7,527
Caroline Cella, Md, MD
Family Medicine — Payments: $5,070
Family Medicine $5,070
Dr. Caroline Blevins
Family Medicine — Payments: $4,853
Family Medicine $4,853
Dr. Rachael Monroe, M.d, M.D
Family Medicine — Payments: $3,658
Family Medicine $3,658
Rafia Samdani, Md, MD
Family Medicine — Payments: $3,130
Family Medicine $3,130